Patient comes with social
It looks like your message got cut off. Could you complete the clinical details? For example:
- Chief complaint — what brought the patient in?
- Social history — what aspects are you referring to? (e.g., smoking, alcohol use, occupation, living situation, substance use)
- Other relevant history — age, sex, comorbidities, vitals, exam findings?
Please share the full details and I'll help you work through the case.
Social anxiety from childhood he is 22
Reading Document
Medical Text Search
social anxiety disorder diagnosis criteria DSM-5
Medical Text Search
social anxiety disorder treatment CBT pharmacotherapy SSRI
GradeResponse
GradeResponse
Here is a structured clinical overview of this case:
Social Anxiety Disorder (SAD) — 22-Year-Old, Childhood Onset
Background
Social anxiety disorder (SAD) is characterized by excessive fear of being negatively evaluated by others in social situations. When onset is in childhood and persists into adulthood, it is typically chronic and may have caused significant functional impairment across school, work, and relationships.
DSM-5 Diagnostic Criteria
| Criterion | Details |
|---|---|
| A | Marked fear/anxiety about social situations involving scrutiny by others |
| B | Fear of acting in a way that will be humiliating or embarrassing |
| C | Social situations almost always provoke fear/anxiety |
| D | Situations are avoided or endured with intense distress |
| E | Fear is out of proportion to actual threat |
| F | Persistent — typically ≥6 months |
| G | Causes significant distress or functional impairment |
| H | Not attributable to substances, medical conditions, or better explained by another disorder |
For this patient: childhood onset + age 22 strongly suggests a long-standing, chronic course — rule out selective mutism (childhood), avoidant personality disorder (overlap), depression (common comorbidity), and substance use (self-medication).
Assessment
- Clinical interview: onset, triggers, avoidance behaviors, functional impact (education, employment, relationships)
- Validated scales: Liebowitz Social Anxiety Scale (LSAS), Social Phobia Inventory (SPIN)
- Comorbidities to screen: MDD, GAD, substance use disorder, avoidant personality disorder
- Developmental history: school refusal, selective mutism, bullying history
Treatment
First-Line
| Modality | Details |
|---|---|
| CBT | First-line, especially for mild-moderate severity. Exposure-based CBT targeting feared social situations is the gold standard. Includes cognitive restructuring + behavioral experiments. |
| SSRI | First-line pharmacotherapy. Options: sertraline, escitalopram, paroxetine (FDA-approved for SAD). Start low, titrate over 4–6 weeks; full effect at 8–12 weeks. |
| SNRI | Venlafaxine — strong evidence, alternative to SSRIs. |
Combination Therapy
- CBT + SSRI together may be more effective than either alone for moderate-to-severe presentations (Assessment and Treatment of Children and Adolescents With Anxiety Disorders, p. 15).
Second-Line / Adjunctive
- Beta-blockers (propranolol): situational use only (e.g., performance anxiety), not for generalized SAD
- Buspirone: limited evidence
- Benzodiazepines: avoid long-term; risk of dependence, no effect on core fear
Key Considerations for This Patient
| Factor | Clinical Implication |
|---|---|
| Childhood onset | Likely deeply entrenched avoidance patterns; CBT may require more sessions |
| Age 22 | High-risk period — career, relationships, independence; functional impairment may be substantial |
| Duration | Long-standing SAD is associated with higher rates of comorbid depression and lower quality of life |
| Self-medication risk | Screen actively for alcohol or substance use as a coping mechanism |
Prognosis
- With treatment (especially combined CBT + SSRI), significant improvement is achievable
- Earlier and more intensive treatment correlates with better outcomes
- Without treatment, SAD tends to follow a chronic, unremitting course
Summary Management Plan
- Confirm diagnosis with structured clinical interview ± LSAS/SPIN
- Screen for comorbidities (depression, substance use, avoidant PD)
- Offer CBT as first-line (exposure-based, ~12–20 sessions)
- Add SSRI (e.g., sertraline 25 mg → titrate to 50–200 mg) for moderate-severe or CBT-unavailable cases
- Monitor response at 8–12 weeks; consider combination if partial response
- Address functional domains: social skills, occupational therapy if needed
This is a shared conversation. Sign in to Orris to start your own chat.